ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Alliance Mining Corp

Alliance Mining Corp (ALM)

0,20
0,00
( 0,00% )
Aktualisiert: 01:00:00

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,20
Gebot
0,14
Fragen
0,21
Volumen
-
0,00 Tagesbereich 0,00
0,07 52-Wochen-Bereich 0,20
Marktkapitalisierung
Handelsende
0,20
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
1.672
Ausgegebene Aktien
8.744.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,65
Gewinn pro Aktie (EPS)
-0,08
Erlöse
-
Nettogewinn
-660k

Über Alliance Mining Corp

Sektor
Miscellaneous Metal Ores,nec
Branche
Miscellaneous Metal Ores,nec
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
-
Alliance Mining Corp is listed in the Miscellaneous Metal Ores sector of the TSX Venture Börse with ticker ALM. The last closing price for Alliance Mining was $0,20. Over the last year, Alliance Mining shares have traded in a share price range of $ 0,07 to $ 0,20.

Alliance Mining currently has 8.744.000 shares in issue. The market capitalisation of Alliance Mining is $1,75 million. Alliance Mining has a price to earnings ratio (PE ratio) of -2.65.

ALM Neueste Nachrichten

Eloxx Pharmaceuticals Announces Key Corporate Accomplishments

Data from Eloxx’s proof-of-concept trial in patients with nonsense mutation Alport Syndrome (NMAS) presented in late-breaking presentation at American Society of Nephrology (ASN) Kidney Week New...

Eloxx Pharmaceuticals Provides Pipeline and Financing Updates

First two subjects dosed in Phase 1 clinical trial of ZKN-013; ZKN-013 is being developed for the potential treatment of rare dermatological and other diseases associated with nonsense mutations...

Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases

Almirall obtains exclusive global rights to develop and commercialize ZKN-013 for the treatment of rare dermatological and other diseases associated with nonsense mutationsZKN-013 is a phase I...

Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases

VANCOUVER, Wash. and BARCELONA, Spain, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, and Almirall S.A. (BME: ALM), a global...

InvestmentPitch Media Video Discusses Alliance Mining’s Results from Vein Sampling Program on Red Rice Lake Gold Property in Manitoba including 44 g/t Gold

VANCOUVER, British Columbia, March 21, 2022 (GLOBE NEWSWIRE) -- Alliance Mining Corp. (TSXV:ALM) announced results from its Fall, 2021, prospecting and sampling program on its Red Rice Lake gold...

Athenex Announces Phased European Launch of Klisyri® (tirbanibulin) for the Treatment of Actinic Keratosis

Klisyri has been approved for the treatment of actinic keratosis by the UK Medicines and Healthcare products Regulatory Agency and will initially be available for prescription in the UK and...

Pulmonx Welcomes Two New Members to Its Board of Directors, Adding Expertise in Consumer Marketing and Medical Device Company...

REDWOOD CITY, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG), a pioneer in providing minimally invasive treatment for patients with severe lung disease, welcomes...

Alabama Power Dividends Declared

BIRMINGHAM, Ala., Oct. 16 /PRNewswire-FirstCall/ -- The board of directors of Alabama Power Company (NYSE:ALM) has declared the regular quarterly dividends on the company's outstanding preferred...

Holding(s) in Company

RNS Number:6368U Alphameric PLC 26 January 2004 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) NAME OF COMPANY ALPHAMERIC PLC 2) NAME OF SHAREHOLDER HAVING A...

Holding(s) in Company

RNS Number:3909U Alphameric PLC 19 January 2004 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) NAME OF COMPANY ALPHAMERIC PLC 2) NAME OF SHAREHOLDER HAVING A MAJOR...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.20.20.25000.2CS
40.115135.2941176470.0850.20.08536000.16770833CS
120.121500.080.20.0716720.145CS
260.11000.10.20.0717790.1101992CS
520.115135.2941176470.0850.20.0734110.09910129CS
156-0.195-49.36708860760.3950.40.0743310.16853714CS
2600.19539000.0051.150.005239050.06104713CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ETUE2gold Inc
$ 0,01
(100,00%)
5k
MVYMoovly Media Inc
$ 0,01
(100,00%)
10k
AAZAzincourt Energy Corp
$ 0,015
(50,00%)
8k
NXSNexus Gold Corp
$ 0,015
(50,00%)
1,5k
WAVEWaverley Pharma Inc
$ 0,015
(50,00%)
1.000
PDVN.PPardus Ventures Inc
$ 0,005
(-75,00%)
5k
TVITVI Pacific Inc
$ 0,005
(-50,00%)
50k
ULTUltra Lithium Inc
$ 0,01
(-33,33%)
1,01M
CLMConsolidated Lithium Metals Inc
$ 0,01
(-33,33%)
1M
LONELithium One Metals Inc
$ 0,01
(-33,33%)
65k
PERUChakana Copper Corp
$ 0,025
(0,00%)
1,97M
MATEBlockmate Ventures Inc
$ 0,085
(0,00%)
1,35M
PNGKraken Robotics Inc
$ 2,32
(-4,92%)
1,2M
MCFMCF Energy Ltd
$ 0,075
(0,00%)
1,02M
ULTUltra Lithium Inc
$ 0,01
(-33,33%)
1,01M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock